» Articles » PMID: 28133450

Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization

Overview
Journal Front Pharmacol
Date 2017 Jan 31
PMID 28133450
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Salvinorin A, a neoclerodane diterpene isolated from , exerts a number of pharmacological actions which are not solely limited to the central nervous system. Recently it has been demonstrated that Salvinorin A inhibits acute inflammatory response affecting leukotriene (LT) production. Since LTs are potent lipid mediators implicated in allergic diseases, we evaluated the effect of Salvinorin A on allergic inflammation and on airways following sensitization in the mouse. Mice were sensitized with s.c. injection of ovalbumin (OVA) on days 1 and 8. Sensitized mice received on days 9 and 12 on the shaved dorsal surface air administration to induce the development of the air-pouches. On day 15 animals were challenged by injection of OVA into the air-pouch. Salvinorin A, administered (10 mg/kg) before each allergen exposure, significantly reduced OVA-induced LT increase in the air pouch. This effect was coupled to a reduction in cell recruitment and Th2 cytokine production. In another set of experiments, mice were sensitized with OVA and both bronchial reactivity and pulmonary inflammation were assessed. Salvinorin A abrogated bronchial hyperreactivity and interleukin (IL)-13 production, without effect on pulmonary inflammation. Indeed cell infiltration and peribronchial edema were still present following diterpenoid treatment. Similarly, pulmonary IL-4 and plasmatic IgE levels were not modulated. Conversely, Salvinorin A significantly reduced LTC production in the lung of sensitized mice. Finally mast cell activity was evaluated by means of toluidine blue staining. Data obtained evidenced that Salvinorin A significantly inhibited mast cell degranulation in the lung. Our study demonstrates that Salvinorin A inhibits airway hyperreactivity induced by sensitization by inhibition of LT production and mast cell degranulation. In conclusion Salvinorin A could represent a promising candidate for drug development in allergic diseases such as asthma.

Citing Articles

Beneficial Effects of (Fisch.) Bunge Extract in Controlling Inflammatory Response and Preventing Asthma Features.

DAvino D, Cerqua I, Ullah H, Spinelli M, Di Matteo R, Granato E Int J Mol Sci. 2023; 24(13).

PMID: 37446131 PMC: 10342042. DOI: 10.3390/ijms241310954.


Mechanisms of Er Chen Tang on Treating Asthma Explored by Network Pharmacology and Experimental Verification.

Ren Y, Zhang H, Yu Z, Yang X, Jiang D Comb Chem High Throughput Screen. 2023; 27(2):227-237.

PMID: 37138477 DOI: 10.2174/1386207326666230503112343.


CD73: Friend or Foe in Lung Injury.

Hu X, Shi N, Zhang J, Zuo Y, Wang X, Zhao Y Int J Mol Sci. 2023; 24(6).

PMID: 36982618 PMC: 10056814. DOI: 10.3390/ijms24065545.


Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: and Anti-Inflammatory Characterization.

Cerqua I, Musella S, Peltner L, DAvino D, Di Sarno V, Granato E J Med Chem. 2022; 65(21):14456-14480.

PMID: 36318728 PMC: 9661480. DOI: 10.1021/acs.jmedchem.2c00817.


Peitu Shengjin Recipe Attenuates Airway Inflammation via the TLR4/NF-kB Signaling Pathway on Chronic Obstructive Pulmonary Disease.

Hu X, Hong B, Sun M Evid Based Complement Alternat Med. 2022; 2022:2090478.

PMID: 35990849 PMC: 9391104. DOI: 10.1155/2022/2090478.


References
1.
Guida F, Luongo L, Aviello G, Palazzo E, De Chiaro M, Gatta L . Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. Mol Pain. 2012; 8:60. PMC: 3522567. DOI: 10.1186/1744-8069-8-60. View

2.
Roviezzo F, Di Lorenzo A, Bucci M, Brancaleone V, Vellecco V, De Nardo M . Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2007; 36(6):757-62. DOI: 10.1165/rcmb.2006-0383OC. View

3.
Deckers J, Madeira F, Hammad H . Innate immune cells in asthma. Trends Immunol. 2013; 34(11):540-7. DOI: 10.1016/j.it.2013.08.004. View

4.
Thivierge M, Stankova J, Rola-Pleszczynski M . IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol. 2001; 167(5):2855-60. DOI: 10.4049/jimmunol.167.5.2855. View

5.
Vortherms T, Roth B . Salvinorin A: from natural product to human therapeutics. Mol Interv. 2006; 6(5):257-65. DOI: 10.1124/mi.6.5.7. View